Livzon Pharmaceutical Group Inc. は1株あたり年間配当金が 0.15 で、利回りは 0.00% です。配当金は 年次 に支払われ、最後の除息日は Jun 13, 2025 でした。
配当利回り
年間配当
除権日
0.00%
$0.15
Jun 13, 2025
支払い頻度
支払率
年次
0.00%
配当履歴
除権日
現金額
記録日
支払日
Jun 13, 2025
$1.1988
Jun 16, 2025
Jul 11, 2025
Jul 8, 2024
$1.482
Jul 9, 2024
Aug 5, 2024
Jul 4, 2023
$1.7439
Jul 5, 2023
Jul 31, 2023
May 31, 2022
$1.5116
Jun 1, 2022
Jun 24, 2022
配当チャート
LVZPF 配当
LVZPF 配当成長率(年間比)
Follow-Up Questions
Livzon Pharmaceutical Group Inc.の現在の配当金と年間配当金はいくらですか?
Livzon Pharmaceutical Group Inc.の配当性向は何ですか?
LVZPFの配当落ち日はいつですか?
Livzon Pharmaceutical Group Inc.はどのくらいの頻度で配当金を支払いますか?
主要データ
前終値
$3.71
始値
$4.35
当日レンジ
$4.35 - $4.35
52週レンジ
$3.2 - $5.22
取引高
1
平均取引高
0
1株当たり利益(TTM)
0.34
配当利回り
--
時価総額
$1.3B
LIVZON PHARMACEUTICAL GROUP INCとは何ですか?
Livzon Pharmaceutical Group Inc is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Zhuhai, Guangdong and currently employs 9,067 full-time employees. Livzon Pharmaceutical Group Inc is a China-based company principally engaged in the research, development, production and sale of pharmaceutical products. The firm's main businesses include chemical drug preparations, biological products, active pharmaceutical ingredients and intermediates, traditional Chinese medicine preparations, diagnostic reagents and equipment, commercial development and functional management. The firm's main products include Ilaprazole (Ilaprazole Enteric-Coated Tablets and Ilaprazole Sodium for Injection), a series of Bismuth Potassium Citrate products, Rabeprazole Sodium Enteric-Coated Capsules, Weisanlian (Bismuth Potassium Citrate Tablets/Tinidazole Tablets/Clarithromycin Tablets), Leuprorelin Acetate Microspheres for Injection, Urofollitropin for Injection, Menotropins for Injection, Voriconazole for Injection and others. The firm mainly operates its businesses in the domestic and overseas markets.